Author： Millet B. Andre C. Deligne H. Olie J-P.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.10, 1999-10, pp. : 1589-1598
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Therapeutic Potential of Kava in the Treatment of Anxiety Disorders
By Singh Y.N.
CNS Drugs, Vol. 16, Iss. 11, 2002-01 ,pp. :
Access to resources
Recommend
The treatment of anxiety disorders in the elderly
By Sheehan D.V. Ray B.A. Sheehan K.H.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Issues in the treatment of anxiety disorders
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :
Escitalopram has potential in anxiety disorders
Inpharma, Vol. 1, Iss. 1335, 2002-01 ,pp. :
Pharmacological treatment of anxiety disorders: an overview
By Leacute pine J.P. Pelissolo A.
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :